Use of clozapine in childhood schizophrenia

T N Srinivasan1, S Latha

  • 1T.N. SRINIVASAN, MD., Research Consultant, Schizophrenia Research Foundation, Anna Nagar East, Chennai 600 102.

Insights

Childhood onset schizophrenia (COS) is rare and severe. Clozapine, a newer antipsychotic, shows promise for effective and safe treatment in pediatric patients, offering an alternative to conventional neuroleptics.

Area of Science:

  • Child and Adolescent Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Childhood onset schizophrenia (COS) is a rare psychiatric disorder with a poorer prognosis than adult-onset schizophrenia.
  • Conventional antipsychotics show inconsistent efficacy in children and carry risks of adverse effects impacting development.
  • Clozapine, an atypical antipsychotic, has demonstrated effectiveness and safety in pediatric schizophrenia, but data from India is limited.

Purpose of the Study:

  • To report the effective and safe use of clozapine in a young girl diagnosed with childhood onset schizophrenia.
  • To contribute to the limited literature on clozapine's application in pediatric schizophrenia in the Indian subcontinent.

Main Methods:

  • This is a case report detailing the treatment of a 9-year-old girl with schizophrenia.
  • The report focuses on the administration and observed effects of clozapine.

Main Results:

  • Clozapine was found to be effective in managing the symptoms of schizophrenia in this pediatric case.
  • The treatment with clozapine was also deemed safe, with no significant adverse effects reported that would impede the child's development.

Conclusions:

  • Clozapine represents a viable and safe therapeutic option for childhood onset schizophrenia, even in very young patients.
  • Further research and case reports from India are needed to establish broader clinical guidelines for clozapine use in pediatric schizophrenia.

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...